Odyssey Therapeutics to Participate in Upcoming Investor Conferences
Odyssey Therapeutics, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, announced that its management team will participate in several investor conferences in September 2026, including Cantor Global Healthcare, Morgan Stanley Global Healthcare, and H.C. Wainwright Global Investment Conferences. The company …